OPRX
OptimizeRx Corp

1,128
Mkt Cap
$146.7M
Volume
973,828.00
52W High
$22.25
52W Low
$3.99
PE Ratio
-3,026.92
OPRX Fundamentals
Price
$7.53
Prev Close
$7.87
Open
$7.74
50D MA
$10.86
Beta
1.61
Avg. Volume
457,450.42
EPS (Annual)
-$1.10
P/B
1.20
Rev/Employee
$714,162.79
$108.72
Loading...
Loading...
News
all
press releases
OptimizeRx Q4 Earnings Call Highlights
OptimizeRx (NASDAQ:OPRX) reported fourth-quarter and full-year fiscal 2025 results that management said exceeded both internal expectations and consensus estimates, driven by growth across...
MarketBeat·2h ago
News Placeholder
More News
News Placeholder
Stock Repurchase Plan Initiated by OptimizeRx (NASDAQ:OPRX) Board of Directors
OptimizeRx (NASDAQ:OPRX - Get Free Report) announced that its board has authorized a share repurchase plan on Thursday, March 5th, RTT News reports. The company plans to repurchase $10.00 million in...
MarketBeat·3h ago
News Placeholder
OptimizeRx (OPRX) Q4 2025 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·7h ago
News Placeholder
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates
OptimizeRx (OPRX) delivered earnings and revenue surprises of +119.36% and +2.10%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·8h ago
News Placeholder
Smith Micro Software, Inc. (SMSI) Reports Q4 Loss, Misses Revenue Estimates
Smith Micro Software (SMSI) delivered earnings and revenue surprises of -14.29% and -7.58%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1d ago
News Placeholder
OptimizeRx Corp. (NASDAQ:OPRX) Given Consensus Rating of "Moderate Buy" by Analysts
OptimizeRx Corp. (NASDAQ:OPRX - Get Free Report) has received a consensus rating of "Moderate Buy" from the eight ratings firms that are presently covering the firm, MarketBeat.com reports. One...
MarketBeat·2d ago
News Placeholder
Intuit (INTU) Q2 Earnings and Revenues Top Estimates
Intuit (INTU) delivered earnings and revenue surprises of +13.25% and +2.75%, respectively, for the quarter ended January 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·7d ago
News Placeholder
OptimizeRx (OPRX) Projected to Post Quarterly Earnings on Thursday
OptimizeRx (NASDAQ:OPRX) will be releasing its Q4 2025 earnings after the market closes on Thursday, March 5. (View Earnings Report at...
MarketBeat·8d ago
News Placeholder
CenterBook Partners LP Invests $6.33 Million in OptimizeRx Corp. $OPRX
CenterBook Partners LP acquired a new stake in shares of OptimizeRx Corp. (NASDAQ:OPRX - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange...
MarketBeat·16d ago
News Placeholder
OptimizeRx Corp. (NASDAQ:OPRX) Given Consensus Recommendation of "Moderate Buy" by Analysts
OptimizeRx Corp. (NASDAQ:OPRX - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the nine research firms that are covering the stock, MarketBeat Ratings reports. One...
MarketBeat·27d ago
<
1
2
...
>

Latest OPRX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.